Much interest has been shown in recent years in the use of chromosomal damage in human circulating lymphocytes as an indicator of absorbed dose of external ionizing irradiation (Evans, 1967; Bender and Brewen, 1969; Dolphin, 1969; Scott, Sharpe, Batchelor, Evans, and Papworth, 1970) . Because of the long mean life of such lymphocytes, induced damage is detectable many years after exposure, making it possible to assess dosage retrospectively, where reconstruction ofdamage in radiation accidents by physical methods has been difficult or impossible (Purrott, Lloyd, Dolphin, Eltham, Platt, Tipper, and Strange, 1973) .
However, surprisingly little has been reported on the effects of therapeutic administration of radioisotopes. Indeed, before the study of patients who had had intra-articular injections of 198Au, there appear to have been only two papers on patients with polycythaemia vera treated by phosphorus 32 (32p), and half a dozen reports on patients treated by iodine 131 (1311) for the control of hyperthyroidism or by ablation doses in the therapy of thyroid cancer.
None of these papers satisfy certain criteria, including numbers of patients, and numbers of cells examined, which are essential for examination of dose-damage relationship, and in most, including understandably the earlier studies, the techniques used and the methods of scoring and presentation of data, do not meet the requirements suggested in UNSCEAR (1969).
The present paper considers five sets of data accumulated in the MRC Population Genetics Unit in Oxford since 1971. Those relating to patients treated by intra-articular injections of 198Au or 90Y, which have already been published (Stevenson, Bedford, Hill, and Hill, 1971b; Stevenson, Bedford, and 11 others, 1973) It was concluded that most phenomena observed were explicable on the basis that the dosage to lymphocytes, even from 195Au, which is also a yemitter, was predominantly from the short range IIparticles in the lymph nodes receiving the drainage from the joints. The patterns of damage and their significance in understanding the circulation of lymphocytes will be discussed by Dr. Dolphin.
The findings in these two studies are summarized in the Table (rows A and B) , which also gives the data for the other three studies mentioned above. In the first two studies the data from follow-up of patients 1 month after injection only are included (two patients having 198Au and seven having 90Y).
Rows C, D, and E in the Papers are in preparation concerning the lipiodol and iodine studies, and in these the data will be presented in full and the literature considered. I propose to concentrate on the parameter offrequency ofdicentric chromosomes as the indicator ofchromosomal damage because this is the one increasingly accepted as the most valid, although the sum dicentric and centric ring chromosome frequencies are used by some authors. The advantages of either parameter are that these types ofchromosome damage are characteristic of radiation damage, and are so uncommon in control subjects (less than 1/2,000 and 1/5,000 respectively), that any found can be attributed to irradiation, with certain reservations I shall leave the discussion of the very difficult subject of lymphocyte dosimetry to others, but it does seem clear that some of the lipiodol injected into a lymphatic vessel reaches the draining nodes in a few minutes, some remains in the nodes for a long period (6 to 8 weeks) even if the node is not damaged (Desprez-Curely, Bismuth, Laugier, and Descamps, 1962;  Richardson, Crosby, Bean, and Dexter, 1966) , and some passes through the nodes. Some of the iodinized oil is broken down and the unchanged remnant becomes broken up into smaller and smaller droplets. Some of these droplets reach the lungs 15 to 20 minutes after injection and some of them are sufficiently small to pass through the pulmonary capillaries. According to Elke (1965) , at 3 days the content in the lungs is about 50 per cent. of the amount injected into lymph vessels. Koehler, Meyers, Skelley, and Schaffer (1964) found that by 6 days only 13 per cent. had been excreted in the urine and elimination from the kidney was much slower thereafter. Clearly, only a careful combination of radiography and activity scanning would yield data which could be related realistically to chromosome damage observed in treated patients. It is obviously unlikely that there is uniform irradiation of body tissues, and that lymph node dosage would be expected to be relatively high, and that lung and kidney dosage would be higher than in other tissues.
The data from the 28 patients who had had oral 13"I are shown in the Table, row E. Three further patients investigated have been excluded because search showed that they had had radiotherapy. It will be seen that the corrected frequency of dicentric chromosomes per 1,000 cells per mCi. is lower than in A, B, or D, and a little higher but not dissimilar to those for the Reading series of 90Y treated patients. However, the 'correction' for interval from treatment to test is rather unrealistic, as for several patients the factor was three or more, multiplying alarmingly any sampling variation. Dr. Dolphin has made careful estimates of the lymphocyte dosimetry from 1311 patients and has attempted to relate them to estimates based on the amount of chromosome damage. On the basis of his physical estimates, he calculated that the mean whole body dose per mCi. of 131J ingestedwould be about 0 6 r, so that the mean dose in the patients reported in the Table would be about 6 r. However, the frequency of dicentrics per cell (not 'corrected') in these patients was 44/4,300 (or 1 per cent.), which is much more than would be expected from an external whole body dose of such size.
Looking at the data as a non-physicist, and bearing in mind that not all the iodine would be absorbed from the gut, that the half life is just over 8 days, and the half life in the thyroid is shorter, and that much of the released energy is y, it is perhaps surprising that the level of damage is so high.
Looking at the Table as a whole, there are a number of points of interest. First, it has to be realized that over 30,000 cells were analysed in the various studies. This is an enormous number, yet, particularly in B, C, and D, the standard errors of the proportions are high. Further to reduce sampling errors to a significant extent, the amount of work involved would be enormous.
In consideration of the first 198Au and 90Y work, it was pointed out that the departure from expectation on a Poisson hypothesis of the distribution of dicentrics in cells was compatible with an explanation of most of the lymphocyte exposure being on lymph nodes, and that the dosage to them varied from zero to very high.
That it was possible with some confidence to recognize the non-Poisson distribution from the data was due to two factors: the relatively high frequency of dicentrics, and the very large numbers of lymphocytes analysed. Neither of these apply to B, C, or D, or to the data of de la Chapelle and others (1972) . It seems important to extend studies of the effects of endolymphatic lipiodol 32P, and of 131I, because the data suggest non-Poisson distributions.
I shall not attempt to discuss the prognostic implications of chromosome damage induced in these ways. They were discussed both at the meeting at Stoke Mandeville in January, 1972, and by Stevenson and others (1973) , and there appears to be nothing to add to these inconclusive arguments.
Finally, as there are many rheumatologists here, may I ask that any who have not received the request for data to enable treated patients to be followed up will get in touch with me; and also will those who have promised to co-operate but have not yet sent completed proformas please do so as soon as possible. 
